Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Clinical trial NCT02650271 · COMPLETED

Trial details

NCT number: NCT02650271
Sponsor: Guangxi Medical University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2021-02-02
Primary completion: 2023-12-25
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.